Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125312191 | 12531219 | 1 | I | 20151107 | 20151217 | 20160706 | 20160706 | EXP | US-PFIZER INC-3119381 | PFIZER | 63.00 | YR | F | Y | 91.00000 | KG | 20160706 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125312191 | 12531219 | 1 | SS | CISPLATIN. | CISPLATIN | 1 | UNK, CYCLIC | U | UNK | 0 | |||||||||
125312191 | 12531219 | 2 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | UNK, CYCLIC | U | UNK | 76517 | SOLUTION FOR INJECTION | ||||||||
125312191 | 12531219 | 3 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK, CYCLIC | U | UNK | 76517 | SOLUTION FOR INJECTION | |||||||
125312191 | 12531219 | 4 | SS | DOCETAXEL. | DOCETAXEL | 1 | UNK, CYCLIC | U | UNK | 202356 | |||||||||
125312191 | 12531219 | 5 | SS | DOCETAXEL. | DOCETAXEL | 1 | UNK, CYCLIC | U | UNK | 202356 | |||||||||
125312191 | 12531219 | 6 | SS | TARCEVA | ERLOTINIB HYDROCHLORIDE | 1 | UNK | Y | UNK | 0 | |||||||||
125312191 | 12531219 | 7 | SS | TARCEVA | ERLOTINIB HYDROCHLORIDE | 1 | UNK, ONCE DAILY, TABLET | Y | 0 | QD | |||||||||
125312191 | 12531219 | 8 | C | VANCOMYCIN | VANCOMYCIN | 1 | UNK | 0 | |||||||||||
125312191 | 12531219 | 9 | C | PROPANOLOL HYDROCHLORIDE | PROPRANOLOL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
125312191 | 12531219 | 10 | C | VENLAFAXINE HYDROCHLORIDE. | VENLAFAXINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
125312191 | 12531219 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
125312191 | 12531219 | 12 | C | HYDROCODONE | HYDROCODONE | 1 | 0 | ||||||||||||
125312191 | 12531219 | 13 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125312191 | 12531219 | 1 | Squamous cell carcinoma of the tongue |
125312191 | 12531219 | 2 | Squamous cell carcinoma of the tongue |
125312191 | 12531219 | 4 | Squamous cell carcinoma of the tongue |
125312191 | 12531219 | 6 | Squamous cell carcinoma of the tongue |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125312191 | 12531219 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125312191 | 12531219 | Dehydration | |
125312191 | 12531219 | Diarrhoea | |
125312191 | 12531219 | Enterocolitis infectious | |
125312191 | 12531219 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125312191 | 12531219 | 2 | 20151104 | 0 | ||
125312191 | 12531219 | 3 | 20151202 | 0 | ||
125312191 | 12531219 | 4 | 20151104 | 0 | ||
125312191 | 12531219 | 5 | 20151202 | 0 | ||
125312191 | 12531219 | 6 | 20151104 | 20151108 | 0 | |
125312191 | 12531219 | 7 | 20151202 | 20151207 | 0 |